Serum Institute of India Pvt Ltd.

- Country
- 🇮🇳India
- Ownership
- Subsidiary
- Established
- 1996-01-01
- Employees
- 1K
- Market Cap
- -
Clinical Trials
72
Trial Phases
5 Phases
Drug Approvals
7
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (70 trials with phase data)• Click on a phase to view related trials
Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults
- Conditions
- Prevention of Malaria Transmission and Clinical Malaria
- Interventions
- Biological: 10µg of R21 with 50µg Matrix-M1Biological: 6µg of Pfs230D1-CRM197 + 10µg of R21 with 50µg Matrix-M1 single vial coformulationBiological: Conjugated Pfs230D1 Vaccine (Pfs230D1-CRM197) For Bedside MixingBiological: R21 Malaria Vaccine (Recombinant) For Bedside MixingBiological: MATRIX-M1 (Adjuvant) For Bedside Mixing
- First Posted Date
- 2025-08-29
- Last Posted Date
- 2025-08-29
- Lead Sponsor
- Serum Institute of India Pvt. Ltd.
- Target Recruit Count
- 1200
- Registration Number
- NCT07147400
- Locations
- 🇲🇱
University of Science, Technique and Technology of Bamako (Usttb), Bamako, Mali
An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine
- Conditions
- Malaria,FalciparumMorality
- First Posted Date
- 2025-06-08
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- Serum Institute of India Pvt. Ltd.
- Target Recruit Count
- 2308
- Registration Number
- NCT07009847
- Locations
- 🇧🇫
Unité de Recherche Clinique de Nanoro (URCN), Institut de Recherche en Sciences de la Santé, Direction Régionale du Centre-Ouest (IRSS-DRCO), Bousse, Boussé, Burkina Faso
🇨🇮Centre de Recherche et de Lutte contre le Paludisme Institut National de Santé Publique, boulevard Nangui Abrogoua près État Major des Armées, Toumodi, Côte D'Ivoire
🇳🇬University of Ilorin Department of Pediatrics University of Ilorin Teaching Hospital, Ilorin, Nigeria, Yenagoa, Bayesla, Nigeria
Dose-Escalating Study of Pfs230D1 in Combination With R21 in Matrix-M in African Adults
- Conditions
- Prevention of Malaria Transmission and Clinical Malaria
- Interventions
- First Posted Date
- 2024-07-18
- Last Posted Date
- 2025-08-17
- Lead Sponsor
- Serum Institute of India Pvt. Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT06507605
- Locations
- 🇲🇱
University of Science, Technique and Technology of Bamako (Usttb), Bamako, Mali
Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV
- Conditions
- Polio ImmunizationHepatitis B ImmunizationHaemophilus Influenzae Type B ImmunizationTetanus ImmunizationDiptheria ImmunizationPertussis Immunization
- Interventions
- Biological: Hexavalent (DTwP-HepB-IPV-Hib) Vaccine Containing Full Dose IPVBiological: Hexavalent (DTwP-HepB-IPV-Hib) Vaccine Containing Reduced Dose IPV
- First Posted Date
- 2024-05-14
- Last Posted Date
- 2024-05-21
- Lead Sponsor
- Serum Institute of India Pvt. Ltd.
- Target Recruit Count
- 1557
- Registration Number
- NCT06413121
- Locations
- 🇧🇩
International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), Dhaka, Bangladesh
🇮🇳Hamdard Institute of Medical Sciences and Research (HIMSR) with Centre for health research & Development, Society for applied studies, Hakeem Abdul Hameed Centenary Hospital (HAHCH), New Delhi, Delhi, India
🇮🇳Manipal Academy of Higher Education, Manipal, Mangalore, Karnataka, India
Clinical Study to Evaluate SIIPL QHPV Vaccine (CERVAVAC®) in Women Living with HIV Aged 15-25 Years
- Conditions
- Human Papillomavirus Infection
- Interventions
- Biological: Cervavac as two dose regimenBiological: Cervavac as three dose regimenBiological: Gardasil as three dose regimen
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- Serum Institute of India Pvt. Ltd.
- Target Recruit Count
- 450
- Registration Number
- NCT06281119
- Locations
- 🇰🇪
Centre For Clinical Research, Kemri, Nairobi, Kenya
🇰🇪Partners in Health and Research Development (Phrd), Thika, Kenya
🇲🇿Manhiça Health Research Center - Manhiça Foundation (CISM-FM), Manhiça, Mozambique
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
